Abstract:The reduction of excessive weight remains a major public health challenge, with control currently limited to a calorie reduction strategy. Currently, attempts are being made at revisiting the fibre hypothesis based on the African studies of Denis Burkitt, that the lack of dietary fibre in the modern diet was responsible for the occurrence of obesity and many of the other non-communicable diseases of what he called “Western civilization”. However, the dilemma is that Burkitt himself stressed that other peoples of his day, such as the Maasai, remained healthy without consuming such high fibre diets. Equally, the present obesity epidemic is accompanied by diseases of a malfunctioning immune system and of poor mental health that do not seem to be adequately explained simply by a deficiency of dietary fibre. Though unknown in Burkitt’s day, an increasing degradation of a mutualistic intestinal microbiome would offer a better fit to the observed epidemiology, especially if the microbiome is not effectively passed on from mother to child at birth. Taking the broader view, in this article we posit a view of the microbiome as a cofactor of mammalian evolution, in which a maternal microbial inheritance complements the parental genetic inheritance of the animal, both engaging epigenetic processes. As this would require the microbiome to be fully integrated with the animal as it develops into an adult, so we have a meaningful evolutionary role for the microbiome–gut–brain axis. By a failure to correctly establish a microbiome–gut interface, the inhibition of maternal microbial inheritance sets the scene for the future development of non-communicable disease: compromised immune system function on the one hand and dysfunctional gut–brain communication on the other. The basic principle is that the fully functioning, diverse, microbiome achieves interkingdom communication by the generation of messenger chemicals, semiochemicals. It is envisaged that the in situ detection of these as yet ill-defined chemical entities by means of an ingestible sensor would indicate the severity of disease and provide a guide as to its amelioration.

Role of the intestine and its gut microbiota in metabolic syndrome and obesity

Microbiome–Gut Dissociation: Investigating the Origins of Obesity

Gut Microbiota and Metabolic Syndrome: Relationships and Opportunities for New Therapeutic Strategies

Role of the intestinal microbiota in contributing to weight disorders and associated comorbidities

Gut microbiota-derived metabolites: implications for metabolic syndrome and therapeutic interventions

Harnessing the Power of the Gut Microbiome: A Review of Supplementation Therapies for Metabolic Syndrome

Gut Microbiota Disorders and Metabolic Syndrome: Tales of a Crosstalk Process

Advances in Gut Microbiota-Targeted Therapeutics for Metabolic Syndrome

The interaction between microbiome and host central nervous system: the gut-brain axis as a potential new therapeutic target in the treatment of obesity and cardiometabolic disease

Upper small intestine microbiome in obesity and related metabolic disorders: A new field of investigation

Is the Gut Microbiota a New Factor Contributing to Obesity and Its Metabolic Disorders?

The complex link between the gut microbiome and obesity-associated metabolic disorders: Mechanisms and therapeutic opportunities

Dietary Strategies for Management of Metabolic Syndrome: Role of Gut Microbiota Metabolites

The role of the gut microbiome and its metabolites in metabolic diseases

The role of gut microbiota in the development of metabolic syndrome

Role of the Microbiome in Energy Regulation and Metabolism

Gut Microbiota, Immunity, and Bile Acid Metabolism: Decoding Metabolic Disease Interactions

Interactions between host genetics and gut microbiome in diabetes and metabolic syndrome

Gut microbiota, obesity and metabolic disorders

Exploring the Gut Microbiota: Key Insights into Its Role in Obesity, Metabolic Syndrome, and Type 2 Diabetes

The Role of Gut Microbiota and Its Produced Metabolites in Obesity, Dyslipidemia, Adipocyte Dysfunction, and Its Interventions